Annual Cash & Cash Equivalents
$83.16 M
+$21.25 M+34.33%
31 December 2023
Summary:
Allogene Therapeutics annual cash & cash equivalents is currently $83.16 million, with the most recent change of +$21.25 million (+34.33%) on 31 December 2023. During the last 3 years, it has fallen by -$100.20 million (-54.65%). ALLO annual cash & cash equivalents is now -54.65% below its all-time high of $183.35 million, reached on 31 December 2020.ALLO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$51.24 M
-$119.43 M-69.98%
30 September 2024
Summary:
Allogene Therapeutics quarterly cash and cash equivalents is currently $51.24 million, with the most recent change of -$119.43 million (-69.98%) on 30 September 2024. Over the past year, it has dropped by -$18.01 million (-26.00%). ALLO quarterly cash and cash equivalents is now -82.57% below its all-time high of $293.93 million, reached on 30 June 2018.ALLO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.3% | -26.0% |
| 3 y3 years | -54.6% | -73.0% |
| 5 y5 years | -10.0% | -68.2% |
ALLO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.6% | +34.3% | -73.0% | +0.4% |
| 5 y | 5 years | -54.6% | +34.3% | -81.7% | +0.4% |
| alltime | all time | -54.6% | -82.6% | +0.4% |
Allogene Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $51.24 M(-70.0%) |
| June 2024 | - | $170.67 M(+234.4%) |
| Mar 2024 | - | $51.04 M(-38.6%) |
| Dec 2023 | $83.16 M(+34.3%) | $83.16 M(+20.1%) |
| Sept 2023 | - | $69.25 M(-55.3%) |
| June 2023 | - | $154.76 M(+40.8%) |
| Mar 2023 | - | $109.93 M(+77.6%) |
| Dec 2022 | $61.90 M(-64.3%) | $61.90 M(-16.7%) |
| Sept 2022 | - | $74.36 M(-22.6%) |
| June 2022 | - | $96.04 M(+13.6%) |
| Mar 2022 | - | $84.51 M(-51.2%) |
| Dec 2021 | $173.31 M | $173.31 M(-8.8%) |
| Sept 2021 | - | $190.02 M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $223.50 M(-5.6%) |
| Mar 2021 | - | $236.87 M(+29.2%) |
| Dec 2020 | $183.35 M(+4.7%) | $183.35 M(+15.9%) |
| Sept 2020 | - | $158.14 M(-43.6%) |
| June 2020 | - | $280.38 M(+106.3%) |
| Mar 2020 | - | $135.90 M(-22.4%) |
| Dec 2019 | $175.13 M(+89.5%) | $175.13 M(+8.8%) |
| Sept 2019 | - | $160.99 M(+43.0%) |
| June 2019 | - | $112.58 M(+21.4%) |
| Mar 2019 | - | $92.75 M(+0.3%) |
| Dec 2018 | $92.43 M(>+9900.0%) | $92.43 M(+11.2%) |
| Sept 2018 | - | $83.14 M(-71.7%) |
| June 2018 | - | $293.93 M |
| Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Allogene Therapeutics?
- What is Allogene Therapeutics annual cash & cash equivalents year-on-year change?
- What is Allogene Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Allogene Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ALLO is $83.16 M
What is the all time high annual cash & cash equivalents for Allogene Therapeutics?
Allogene Therapeutics all-time high annual cash & cash equivalents is $183.35 M
What is Allogene Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ALLO annual cash & cash equivalents has changed by +$21.25 M (+34.33%)
What is Allogene Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALLO is $51.24 M
What is the all time high quarterly cash and cash equivalents for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly cash and cash equivalents is $293.93 M
What is Allogene Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ALLO quarterly cash and cash equivalents has changed by -$18.01 M (-26.00%)